178 related articles for article (PubMed ID: 34869273)
1. Pilot Study Assessing the Impact of Intrathecal Administration of Variants AAV-PHP.B and AAV-PHP.eB on Brain Transduction in Adult Rhesus Macaques.
Arotcarena ML; Dovero S; Biendon N; Dutheil N; Planche V; Bezard E; Dehay B
Front Bioeng Biotechnol; 2021; 9():762209. PubMed ID: 34869273
[TBL] [Abstract][Full Text] [Related]
2. Enhanced CNS transduction from AAV.PHP.eB infusion into the cisterna magna of older adult rats compared to AAV9.
Chatterjee D; Marmion DJ; McBride JL; Manfredsson FP; Butler D; Messer A; Kordower JH
Gene Ther; 2022 Jun; 29(6):390-397. PubMed ID: 33753910
[TBL] [Abstract][Full Text] [Related]
3. AAV-PHP.B Administration Results in a Differential Pattern of CNS Biodistribution in Non-human Primates Compared with Mice.
Liguore WA; Domire JS; Button D; Wang Y; Dufour BD; Srinivasan S; McBride JL
Mol Ther; 2019 Nov; 27(11):2018-2037. PubMed ID: 31420242
[TBL] [Abstract][Full Text] [Related]
4. CNS Transduction Benefits of AAV-PHP.eB over AAV9 Are Dependent on Administration Route and Mouse Strain.
Mathiesen SN; Lock JL; Schoderboeck L; Abraham WC; Hughes SM
Mol Ther Methods Clin Dev; 2020 Dec; 19():447-458. PubMed ID: 33294493
[TBL] [Abstract][Full Text] [Related]
5. More expansive gene transfer to the rat CNS: AAV PHP.EB vector dose-response and comparison to AAV PHP.B.
Dayton RD; Grames MS; Klein RL
Gene Ther; 2018 Aug; 25(5):392-400. PubMed ID: 30013186
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein E, low-density lipoprotein receptor, and immune cells control blood-brain barrier penetration by AAV-PHP.eB in mice.
Xie BS; Wang X; Pan YH; Jiang G; Feng JF; Lin Y
Theranostics; 2021; 11(3):1177-1191. PubMed ID: 33391529
[No Abstract] [Full Text] [Related]
7. Use of CRISPR/Cas9-mediated disruption of CNS cell type genes to profile transduction of AAV by neonatal intracerebroventricular delivery in mice.
Torregrosa T; Lehman S; Hana S; Marsh G; Xu S; Koszka K; Mastrangelo N; McCampbell A; Henderson CE; Lo SC
Gene Ther; 2021 Aug; 28(7-8):456-468. PubMed ID: 33612827
[TBL] [Abstract][Full Text] [Related]
8. Intravenous administration of the adeno-associated virus-PHP.B capsid fails to upregulate transduction efficiency in the marmoset brain.
Matsuzaki Y; Konno A; Mochizuki R; Shinohara Y; Nitta K; Okada Y; Hirai H
Neurosci Lett; 2018 Feb; 665():182-188. PubMed ID: 29175632
[TBL] [Abstract][Full Text] [Related]
9. Efficient retinal ganglion cells transduction by retro-orbital venous sinus injection of AAV-PHP.eB in mature mice.
Tang M; Zhong L; Rong H; Li K; Ye M; Peng J; Ge J
Exp Eye Res; 2024 Jul; 244():109931. PubMed ID: 38763353
[TBL] [Abstract][Full Text] [Related]
10. Delivering genes across the blood-brain barrier: LY6A, a novel cellular receptor for AAV-PHP.B capsids.
Huang Q; Chan KY; Tobey IG; Chan YA; Poterba T; Boutros CL; Balazs AB; Daneman R; Bloom JM; Seed C; Deverman BE
PLoS One; 2019; 14(11):e0225206. PubMed ID: 31725765
[TBL] [Abstract][Full Text] [Related]
11. AAV-PHP.eB transduces both the inner and outer retina with high efficacy in mice.
Palfi A; Chadderton N; Millington-Ward S; Post I; Humphries P; Kenna PF; Farrar GJ
Mol Ther Methods Clin Dev; 2022 Jun; 25():236-249. PubMed ID: 35474956
[TBL] [Abstract][Full Text] [Related]
12. Better Targeting, Better Efficiency for Wide-Scale Neuronal Transduction with the Synapsin Promoter and AAV-PHP.B.
Jackson KL; Dayton RD; Deverman BE; Klein RL
Front Mol Neurosci; 2016; 9():116. PubMed ID: 27867348
[TBL] [Abstract][Full Text] [Related]
13.
Batista AR; King OD; Reardon CP; Davis C; Shankaracharya ; Philip V; Gray-Edwards H; Aronin N; Lutz C; Landers J; Sena-Esteves M
Hum Gene Ther; 2020 Jan; 31(1-2):90-102. PubMed ID: 31696742
[TBL] [Abstract][Full Text] [Related]
14. Use of high-content imaging to quantify transduction of AAV-PHP viruses in the brain following systemic delivery.
Smith EJ; Farshim PP; Flomen R; Jones ST; McAteer SJ; Deverman BE; Gradinaru V; Bates GP
Brain Commun; 2021; 3(2):fcab105. PubMed ID: 34131644
[TBL] [Abstract][Full Text] [Related]
15. Widespread transduction of astrocytes and neurons in the mouse central nervous system after systemic delivery of a self-complementary AAV-PHP.B vector.
Rincon MY; de Vin F; Duqué SI; Fripont S; Castaldo SA; Bouhuijzen-Wenger J; Holt MG
Gene Ther; 2018 Apr; 25(2):83-92. PubMed ID: 29523880
[TBL] [Abstract][Full Text] [Related]
16. Structural basis of receptor usage by the engineered capsid AAV-PHP.eB.
Jang S; Shen HK; Ding X; Miles TF; Gradinaru V
Mol Ther Methods Clin Dev; 2022 Sep; 26():343-354. PubMed ID: 36034770
[TBL] [Abstract][Full Text] [Related]
17. Development of CNS tropic AAV1-like variants with reduced liver-targeting following systemic administration in mice.
Drouyer M; Merjane J; Nazareth D; Knight M; Scott S; Liao SHY; Ginn SL; Zhu E; Alexander IE; Lisowski L
Mol Ther; 2024 Mar; 32(3):818-836. PubMed ID: 38297833
[TBL] [Abstract][Full Text] [Related]
18. NeuroD1 Regulated Endothelial Gene Expression to Modulate Transduction of AAV-PHP.eB and Recovery Progress after Ischemic Stroke.
He X; Wang X; Wang H; Wang T; Yang F; Chen Y; Pei Z; Bai Y; Li W; Wu Z; Chen G
Aging Dis; 2023 Dec; ():. PubMed ID: 38270116
[TBL] [Abstract][Full Text] [Related]
19. Efficient whole brain transduction by systemic infusion of minimally purified AAV-PHP.eB.
Konno A; Hirai H
J Neurosci Methods; 2020 Dec; 346():108914. PubMed ID: 32810474
[TBL] [Abstract][Full Text] [Related]
20. Focused ultrasound as a novel strategy for noninvasive gene delivery to retinal Müller glia.
Touahri Y; Dixit R; Kofoed RH; Miloska K; Park E; Raeisossadati R; Markham-Coultes K; David LA; Rijal H; Zhao J; Lynch M; Hynynen K; Aubert I; Schuurmans C
Theranostics; 2020; 10(7):2982-2999. PubMed ID: 32194850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
